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Cystic ﬁbrosisThe cystic ﬁbrosis transmembrane conductance regulator (CFTR) is the onlymember of the ATP-binding cassette
(ABC) superfamily that functions as a chloride channel. The predicted structure of CFTR protein contains two
membrane-spanning domains (MSDs), each followed by a nucleotide binding domain (NBD1 and NBD2). The
opening of the Cl− channel is directly linked to ATP-driven tight dimerization of CFTR'sNBD1 andNBD2 domains.
The presence of a heterodimeric interfaces (HI) region in NBD1 and NBD2 generated a head to tail orientation
necessary for channel activity. This process was also suggested to promote important conformational changes
in the associated transmembrane domains of CFTR, which may impact the CFTR plasma membrane stability. To
better understand the role of the individual HI region in this process, we generated recombinant CFTR protein
with suppressedHI-NBD1 andHI-NBD2. Our results indicate that HI-NBD2deletion leads to the loss of the dimer-
ization proﬁle of CFTR that affect its plasma membrane stability. We conclude that, in addition to its role in Cl−
transport, HI-NBD2 domain confers membrane stability of CFTR by consolidating its quaternary structure
through interactions with HI-NBD1 region.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Cysticﬁbrosis (CF) is a lethal genetic disease caused by a lack of func-
tional cystic ﬁbrosis transmembrane conductance regulator (CFTR), an
apical Cl− channel in epithelial cells [1–3].
CFTR is a member of the ATP Binding Cassette (ABC) superfamily
made of two membrane-spanning domains (MSDs), which form the
channel pore, two cytoplasmic nucleotide-binding domains (NBDs),
which regulate channel gating [4], and a unique phosphorylated cyto-
plasmic regulatory domain (RD) that regulates channel activity [5].
The most prevalent CFTR mutation, a deletion of phenylalanine at
position 508 in NBD1 (F508del), accounts for approximately 70% of all
CF chromosomesworldwide [6]. F508delmutation impairs CFTR folding
causing its retention in the endoplasmic reticulum (ER) and rapid deg-
radation by the ubiquitin-proteasome system [7]. Restoring ER trafﬁck-
ing reveals that F508del-CFTR has a six-fold fastermetabolic turnover atSV, CEA-Grenoble, 17 rue des
harouga).the plasmamembrane (PM) [8]where, compared towild-type (wt), the
channel exhibits a highly unstable gating kinetic [9] and a thermal insta-
bility proﬁle [10].
NBD domains are characteristic features of the ABC transporters su-
perfamily. These domains contain several motifs important for their
function and that are highly conserved in most ABC-proteins [11]. The
β subdomain (or “head”) of the NBDs contains a F1-type ATPase core
with conserved Walker A and B motifs [12]. The α-helical subdomain
(or “tail”) is unique to ABC proteins and contains the ABC signature se-
quence (LSGGQ). The two subdomains are linked by a region with a
highly conserved glutamine called Q-loop which interacts with the γ
phosphate of bound ATP [13,14]. In addition to these binding interac-
tions, the NBD domains contain a switch region (or H-motif) and a
more structurally diverse α-helical domain [15].
In CFTR, the sequence similarity between both NBDs is only 29% [1].
As a consequence, two principal sites are created. The ﬁrst one is formed
by the Walker motifs of the NBD2 head and the signature sequence of
the NBD1 tail subdomain that actively hydrolyzes ATP [16]. The second
site formed by the NBD1 head and the NBD2 tail subdomains is catalyt-
ically inactive [17]. Biochemical studies and single-channel kinetic
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channel is coupled with formation and dissociation of an NBD1–NBD2
intramolecular dimer [18,19].
Based on modeling [11,20] and biochemistry studies [21], the puta-
tive heterodimeric interface (HI) for NBD1 and NBD2 encompasses a
dual area. Site A with Walker A, B, and H motifs from NBD1 and non-
canonical Walker C from NBD2, and site B with the canonical motifs
Walker A, B, and H-motif from NBD2 juxtaposed against Walker C
from NBD1. The region also includes Walker lysine 464 and 1250 resi-
dues that are located in site A and site B, respectively [21]. These results
suggest that formation/dissociation of tight NBDdimersmight also cou-
ple the hydrolytic cycle to functionally important conformational
changes in the associated transmembrane domains of CFTR, which
may impact the behavior of CFTR in the plasma membrane. However,
to date, there is no empirical evidence available to directly support
this hypothesis.
To show that NBD1–NBD2dimerization hasmore than one function-
al role, we have evaluated the impact of internal deletion of the HI-
NBD1 or HI-NBD2 on biosynthesis, folding and assembly, glycosylation,
cellular trafﬁcking, membrane stability, function, and dimerization of a
full-length CFTR. Our results showed that internal deletion of HI-NBD1
mimic the F508del mutation effect on CFTR protein. However, HI-
NBD2 deletion (N1/−) does not impair thematuration of CFTR, but affect
its plasmamembrane function and stability. TheN1/−proteinwas rapid-
ly internalized and degraded by the proteasomal pathway even with a
normal protease susceptibility and thermo-stability/-aggregation pro-
ﬁle compared to the wt protein. In contrast, PFO- and DDM-PAGE
revealed that the dimerization proﬁle was absent for N1/−compared
to wt-CFTR. These results were substantiated by the Duo-Link and UV-
photo-activated amino acid data, suggesting that HI-NBD2 domain
contributes to CFTRdimerization, a quaternary structure that is required
for the stability of CFTR complex-glycosylated form at the plasma
membrane.
2. Materials and methods
2.1. Cell lines
To avoid the possible impact of clonal variations on CFTR trafﬁcking,
experiments were carried out both in transient and stable heterologous
expression systems.
Baby hamster kidney (BHK) cells, stably expressing the wt and mu-
tant (dF, N1/−, N1⁎/−, N−/2) CFTR with or without carboxyl-terminal
hemagglutinin (HA)-epitope, were isolated and maintained as de-
scribed previously [22]. At least 50 individual clones were combined
after antibiotic selection and expanded for subsequent experiments.
COS7 cells were transiently transfected or cotransfected with the
pCDNA3.1 plasmid containing wt or mutant CFTR DNA using the
FuGENE6 (Roche Applied Science, France). BHK and COS7 cells were
grown in DMEM/F-12 (5% fetal bovine serum [FBS]) and in DMEM
(10% of FBS), respectively, at 37 °C under 5% CO2.
2.2. Antibodies and reagents
Antibodies (Abs) were obtained from the following sources; mono-
clonal anti-CFTR Ab L12B4 (recognizing 386–412 residues of the NBD1)
and M3A7 (recognizing 1365–1395 residues at the C terminus of the
NBD2) (Millipore Bioscience Research Reagents, CA), and CF3 (recog-
nizing 103–117 residues of the ﬁrst extracellular loop [ECL1]) (Abcam,
France). Mouse monoclonal anti-HA and anti-Myc were respectively
from Covance Innovative Antibodies (France) and Sigma-Aldrich
(France). Endoglycosidase H (Endo H) and peptide-N-(N-acetyl-β-
glucosaminyl) asparagine amidase (PNGase F) were purchased from
New England Biolabs (France), and other chemicals were obtained
from Sigma-Aldrich (France) at highest grade available.2.3. Splicing by overlap extension (SOE) reaction to generate the different
CFTR constructs
Internal NBD1 and/or NBD2 domain deletions, and/or permutation
in a full length CFTR were accomplished by the splicing by overlap ex-
tension by polymerase chain reaction (SOE by PCR) [23] without intro-
ducing an extra-enzymatic restrictions sites. Plasmids pcDNA3.1
containing C-terminal HA-tagged wt- or F508del-CFTR were used as
templates for the two rounds of PCRnecessary tomake all CFTRmutants
listed in Fig. 1A. Following the ﬁrst stage of PCR, the PCR products were
gel puriﬁed (GeneClean Turbo, Qbiogen) and used in the second-stage
reaction. The second-stage PCR fragments were gel puriﬁed, digested,
and ligated to the ﬂanking 5′ and 3′ remaining sequence elements to
produce the ﬁnal construct.
Digestions were performed by internal enzymatic restriction sites
ApaI/Eco72I for the mutant CFTR without HI-NBD2 region (N1/−), and
by BsrGI/BsgI for mutant CFTR without HI-NBD1 region (N−/2). CFTR
cDNA constructs were subcloned, for stable expression, into the pNut
expression vector. Both C-terminal HA- and Myc-tagged wt- and
F508del-CFTR constructs were kindly provided by Dr. G. Lukacs (McGill
University, Montréal, Canada). All constructs were sequence veriﬁed.
2.4. Metabolic labeling and immunoprecipitation
Metabolic labeling and immunoprecipitation were performed es-
sentially as described previously [22]. Cells were pulse-labeled and
chased at the indicated temperature for the time intervals speciﬁed
for each experiment. Membrane proteins were solubilized in 1 ml of
RIPA buffer (150 mM NaCl, 20 mM Tris–HCl, 1% Triton X-100, 0.1%
SDS, and 0.5% sodium deoxycholate, pH 8.0) supplemented with
protease inhibitors (10 μg/ml leupeptin and pepstatin, 0.5 mM PMSF,
and 10 mM iodoacetamide). Immunoprecipitates obtained with anti-
HA or M3A7 and L12B4 anti-CFTR mAbs, were analyzed by SDS-
polyacrylamide gel electrophoresis and ﬂuorography. The radioactivity
incorporated was quantiﬁed using a PhosphorImager (Molecular
Dynamics) with ImageQuant software (Molecular Dynamics).
2.5. Immunoﬂuorescence microscopy
Immunolocalization of full-length or mutant CFTR was analyzed in
transiently transfected COS7 cells by laser confocal ﬂuorescencemicros-
copy. The cellular localization were visualized with murine monoclonal
anti-HA and ﬂuorescein-conjugated donkey anti-mouse antibody
(Jackson ImmunoResearch Laboratory Inc.) in 4% paraformaldehyde-
ﬁxed, permeabilized cells. Single optical sections were obtained on an
LSM 510 ﬂuorescence laser confocal microscope (Carl Zeiss, France)
with a 63× objective.
2.6. Electrophysiology
Whole cell currentswere recorded by themethod of Hamill et al. [24]
as detailed previously [25]. CFTR-dependent Cl− currents were mea-
sured using the whole-cell conﬁguration of the patch-clamp technique.
Cells were cultured on Petri dishes and transferred to the stage of an
inverted TMD300 microscope (Nikon AG, Küsnacht, Switzerland).
Patch electrodes (2–6 MΩ) were ﬁlled with a solution containing
(in mM): 139 KCl, 1 NaCl, 2 MgCl2, 0.5 CaCl2, 5.5 EGTA, buffered to
pH 7.2 with 10 mM Hepes-KOH. Throughout the recordings, cells were
superfused with a solution containing (in mM) 136 NaCl, 4 KCl, 1
CaCl2, 1 MgCl2, 2.5 glucose and buffered to pH 7.4 with 10 mM HEPES-
NaOH. Junction potentials were nulled immediately before seal forma-
tion. After the establishment of thewhole-cell conﬁguration, capacitative
currents were compensated and membrane currents were recorded
from 20 ms voltage pulses from−50 mV to +30 mV in 10 mV incre-
ments. A mixture of 1 mM, 8-(4-chlorophenylthio)-cAMP (CPT-cAMP)
and 10 μM forskolin was then added to the external solution to activate
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Fig. 1. Schematic cartoon of HA-tagged CFTR constructs and the respective heterodimer interface region of NBD1 and NBD2 domains. A. CFTR transmembrane domains (TMDs) are shown
as green boxes, NBD1 and NBD2 as red and orange boxes, respectively, and the R domain as white circle. Deletions are indicated as hatched boxes. All the constructs harbor the hemma
agglutinin (HA) epitope tag at theC-terminus. B. Scale linear CFTRmap showing positions of theheterodimer interface (HI) ofNBD1 (Phe433-Ile586) andNBD2 (Thr1220-Arg1386) region
with their respective motives. Arrows indicate the residues that correspond to Phe508. The epitopes for the monoclonal antibodies are marked L12B4 and M3A7.
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2-kHz sampling rate using Pulse software connected to an EPC-9
patch-clamp ampliﬁer (Heka Elektronik, Lambrecht, Germany). For off-
line analysis of the data, the average membrane current recorded at
+30mVwas calculated for each sweep andnormalized to the cell capac-
itance to account for variations in cell size.2.7. In situ proximity ligation assay (PLA) in cultured COS7 cells
Weused, according to themanufacturer's instructions (Olink Biosci-
ence, Uppsala, Sweden), the in situ proximity ligation assay (PLA)-based
methodology for in situ visualization and quantiﬁcation of the role of
NBD2 domain in CFTR dimerization in intact cells.
Cells were grown on coverslips and co-transfected with C-terminal
tagged CFTR-HA and CFTR-Myc as described in the “Cell lines” section.
Prior to their use in proximity ligation experiments, CFTR-HA and
CFTR-Myc tagged constructs have been characterized. Immunoﬂuores-
cence staining and immunoblot detection of the epitope-tagged pro-
teins in transiently transfected cell lines conﬁrmed that both tags, HA
and Myc, did not affect neither the biochemistry nor the cell biology of
the tree constructs (not shown).
Transfected cells were washed, ﬁxed, permeabilized, and blocked as
described previously [22]. Then, the cells were incubated overnight at
4 °C with mouse anti-Myc (DSHB, University of Iowa) and rabbit anti-
HA (Covance, France) [26]. Following incubation with anti-mouse (−)
and anti-rabbit (+) secondary probes, the cells were incubated with
free nucleotides for hybridization, DNA ligation and ampliﬁcation as de-
scribed previously [26]. The cellular ﬂuorescence was examined with a
Zeiss Axiovert 200 M epiﬂuorescence microscope under a 63× objec-
tive. Negligible amounts of PLA signal were detected in the absence of
HA orMyc tag in CFTR constructs andwhen using one primary antibody
(for CFTR-Myc or CFTR-HA).2.8. UV-photo-cross-linking using photo–amino acids
BHK cells were cultured as describe in the “Cell lines” section. After
chasing in the presence of LM-4 medium (DMEM lacking methionine
(Met) and leucine (Leu)), the cells were incubated for 22 h with LM-4
medium supplemented with photo-amino acids at a ﬁnal concentration
of 4 mM for photo-Leu and 1.7 mM for photo-Met. After incubation, the
cells were washed and UV-irradiated for 1–3 min at a distance of 38 cm
from the light source (illuminated area was 105-mmdiameter). The t1/2
for photoactivation, determined following the 350-nmdiazirine absorp-
tion peak, was 20 s. The cell mortality was increased, compared to the
control, after 10min of irradiation [27]. Lysis of cells, immunoprecipita-
tion, SDS-PAGE, and immunoblotting using anti-HA Abwere performed
as described [22]. Immunoblotting of early endosome antigen 1 (EEA1)
was performed using the mouse monoclonal anti-EEA1 Ab (Sigma-
Aldrich, France) and ECL.
2.9. Biotinylation of cell surface CFTR
The cell surface expression of thewt andmutants CFTRwas evaluat-
ed using biotinylation assays [22]. After biotinylation and solubilization,
the biotinylated CFTR was afﬁnity-isolated on streptavidin-Sepharose
(Sigma-Aldrich), separated with SDS-polyacrylamide gel electrophore-
sis, and visualized with anti-HA Abs and Enhanced Chemiluminescence
(ECL; Covalab).
2.10. Electrophoresis and immunoblotting
SDS-PAGE, PFO-PAGE and DDM-PAGE were carried out as described
previously [28–30]. CFTR immunoblotting was performed as described
previously [8]. Immunoblottingwas performed usingmousemonoclonal
L12B4, M3A7, CF3, Mab 24.1, anti-R domain antibodies or anti-HA
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conjugated sheep anti-mouse IgG and ECL. Immunoblotting of Na+/K+-
ATPase α1-subunit was performed with the mouse monoclonal (α6F,
DSHB, University of Iowa) antibodies. Immunoblots, withmultiple expo-
sures, were quantiﬁed using DuoScan transparency scanner and N.I.H.
Image 6.1 software (developed by the National Institutes of Health and
available at their web site).
2.11. Microsome preparation and limited proteolysis
Nitrogen cavitation and differential centrifugationwere used to pre-
pare microsome enriched fraction. As described previously [30], themi-
crosome fractions were subjected to the limited proteolysis digestion.
PMSF (phenylmethylsulfonyl ﬂuoride) was used to stop the reaction
and samples were immediately denatured at 37 °C for 20 min in the
presence of the 2× Laemmli sample buffer (LSB).
2.12. Thermoaggregation assay
Thermoaggregation assays were performed as described previously
[8]. Following the solubilization of BHK cells in LSB, the aggregation ten-
dency of wt and mutant CFTR was compared by exposing the lysate to
temperatures ranging from 37 to 100 °C for 5min. SDS-resistantmacro-
molecular aggregates were sedimented with centrifugation (14,000 ×g
for 15 min). Where indicated, heat denaturation was performed in LSB
supplemented with 8 M urea. Monomeric mutant and wt CFTR remain-
ing in the supernatant were measured with quantitative immunoblot-
ting using anti-HA Abs and ECL.
2.13. ATP afﬁnity column binding of wt- and mutants CFTR
The capacity of wt- and mutant CFTR to bind ATP was evaluated as
described previously [31]. Stably transfected BHK-21 cells werewashedB
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Fig. 2. Expression, glycosylation, and temperature rescuing proﬁle of wild type (wt) andmutant
extract of a stably (A) or transiently (B) transfected BHK-21 and COS-7 cell, respectively. The
C. Glycosylation proﬁle of wt and mutants CFTR using endoglycosidase H (H) or peptide-N-g
CFTR upon cells overnight incubation in medium supplemented with 10% glycerol at 26 °C. In a
by the indicated anti-CFTR or anti-HA mAb (HA, L12B4, or M3A7), and revealed by enhanced c
open arrowheads, core-glycosylated CFTR.in hypotonic lysis buffer (7.5 mM Tris pH 7.4) and incubated 5 min in
the same buffer with 200 μM sodium orthovanadate and 0.1 mM
EGTA. Cells were centrifuged at 14,000 ×g for 5 min and the pellet
were resuspended in extraction buffer (0.2% Triton X-100 (v/v),
150 mM NaCl, 20 mM Tris pH 7.4) with 1 mM PMSF. The solubilized
protein fraction was then added to the ATP-agarose, and the mixture
was rotated at 4 °C for 1 h. The mixture was then washed and boiled
in the presence of 2× LSB to release bound CFTR. Released protein
was subjected to SDS-PAGE and immunoblot analysis using anti-HA
Abs and ECL detection system.
2.14. Statistical analysis
All our experiments were repeated at least three times. Results are
means ± S.E.M. Two-tailed P values were calculated at 95% conﬁdence
level with the unpaired t-test, using Sigma Plot software (Systat Soft-
ware, Inc.).
3. Results
3.1. Recombinant CFTR proteins with deleted NBD1 or NBD2 heterodimeric
interface (HI)
To determine if HI-NBD1/HI-NBD2 heterodimerization can achieved
other roles than controlling the activity of CFTR Cl− channel, we used
thepowerful SOEbyPCRmethod [23] to generate different recombinant
full length CFTRs in which the HI-NBD1 or HI-NBD2 sequence was sup-
pressed (Fig. 1A). Based on x-ray crystallographic [11,32,33], biochemi-
cal [34], and modeling studies [35], the corresponding region were
designed to contain all conserved consensus sequences critical for
their role in NBD domain heterodimerization. The HI sequence there-
fore, were deﬁned as starting from amino acid F433 to amino acid
I586 for HI-NBD1, and from T1220 to R1386 for HI-NBD2 (Fig. 1B).- -H HF F
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lycosidase F; PNGase F (F). D. Correction of the processing defects observed for mutants
ll our experiments (A, B, C and D), the polypeptides were separated by SDS-PAGE, probed
hemiluminescence assays (ECL, Covalab). Filled arrowheads, complex-glycosylated CFTR;
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The steady-state level of mutant CFTRs was determinedwith immu-
noblotting using three monoclonal antibodies (mAbs) recognizing
respectively the amino acids 386–412 (L12B4), the amino acids
1365–1395 (M3A7), and the C-terminal HA tag (Fig. 1A and B).
Both core- (MW ~170 kDa) and complex-glycosylated (MW
~140 kDa) forms were detected in stably (BHK-21) and transiently
(COS-7) transfected cells with wt-CFTR, while only core-glycosylated
form was detected in F508del-CFTR transfected cell lines (Fig. 2A and
B, lanes 2 and 3).
Like F508del mutation, deletion of the putative HI-NBD1 region
(N−/2) was not permissive for CFTR maturation (Fig. 2A and B,
lane 5). In contrast, deletion of the HI-NBD2 region (N1/−) generated a
pattern similar to wt-CFTR, with a major band on the immunoblot con-
sistent with the presence of complex N-linked oligosaccharide chains
(Fig. 2A and B, lane 4). This was conﬁrmed by the susceptibility of
N1/−construct to digestion by the endoglycosidase-F (F) but not by
the endoglycosidase-H (H) (Fig. 2C). The presence of the F508delmuta-
tion in the N1/−construct (N1⁎/−) prevented its maturation when cells
were grown at 37 °C (Fig. 2A and B, lane 6) but, as with the full-length
F508del protein (dF), some degree of maturation occurs after overnight
treatment with glycerol at 26 °C (Fig. 2D).A
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but inhibits its Cl− channel activity
To conﬁrm that the complex-glycosylated form of N1/−-CFTR
had proceeded to the Golgi and possibly beyond, immuno-
ﬂuorescence, cell surface biotinylation and functional assays were per-
formed in COS-7 and BHK cells. As expected for an exogenously
expressed protein, the wt-CFTR bearing C-terminal HA epitope was de-
tected at the cell surface as well as intracellular membranes (Fig. 3A,
wt). In contrast, immunodetection of the F508del-CFTR was restricted
to a perinuclear distribution reﬂective of the ER (Fig. 3A, dF). Consistent
with the immunoblotting and endoglycosidase results, all the different
CFTR constructs (N−/2 and N1⁎/−) failed to reach the plasmamembrane
except for N1/−-CFTR construct (Fig. 3A, N1/−). Similar results were ob-
tained in BHK-21 cells stably expressing the different CFTR constructs
(Fig. S1A).
The targeting of the complex-glycosylated N1/−-CFTR to the plasma
membrane was conﬁrmed by cell surface biotinylation. Both N1/−and
wt-CFTR were amenable to biotinylation, in contrast to the ER-
resident core-glycosylated F508del-CFTR (Fig. 3B). Densitometric analy-
sis revealed that, compared to wt-CFTR, only ~35% of the biotinylated
N1/−-CFTR is detected at the plasmamembrane (Fig. 3C). Similar quan-
tity was estimated by immunoblot densitometric analysis of theB
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was observed for all the other CFTR constructs (data not shown).
To determine if N1/−-CFTR construct has any functional capability, its
ability to generate CFTR chloride channel activity was tested. First, we
demonstrate that deletion of HI-NBD1 or HI-NBD2 domains did not
affect the capacity of CFTR protein to bind ATP (Fig. 3D). Wt- and
N1/−-CFTR bind ATP-agarose in a quantitatively comparable and revers-
ible manner (Fig. 3D). Next, patch-clamp whole cell recordings were
performed on BHK-21 cells stably transfected with wt and mutant
CFTRs. Only the expression of the wt-CFTR conferred cAMP-stimulated
whole cell currents (Fig. 3E, wt). N1/−-CFTR, which is detected at the
plasma membrane, was unaffected by cAMP stimulation (Fig. 3E N1/−),
indicating, as reported previously [9], that the HI-NBD2 domain is re-
quired for CFTR Cl− channel activity.3.4. HI-NBD2 domain deletion delays CFTR maturation without affecting
its efﬁciency
The folding efﬁciency of N1/−-CFTR was determined by monitoring
the conversion of core-glycosylated protein to the complex-glycosylated
form (Fig. 4A). The efﬁciency of this process for the stably expressed
N1/−-CFTR ranged between 25 and 29%, which was comparable to
values for wt-CFTR (Fig. 4A and B). Interestingly, the deletion of
HI-NBD2 region delayed the CFTR maturation process. At 30 min, only
~15% of N1/−matured compared to wt-CFTR (~23%) (Fig. 4A and B).
The remaining core-glycosylated wt-, F508del-, N1/−-, N1⁎/−-, andA B
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3.5. The complex-glycosylated form of N1/--CFTR is unstable and is degraded
in a proteasome-dependent manner
In principle, accelerated degradation, defective post-translational
folding, and decreased stability of themutant transcripts, or a combina-
tion of these processes, could explain the decrease in the expression
levels of complex-glycosylated N1/−-CFTR (Figs. 2A, B and 3B, C). To dis-
criminate between these possibilities, additional experimentswere thus
performed.
The rate of biosynthesis of the N1/−-CFTR was determined by pulse
labeling of the newly synthesized proteins and by quantifying the incor-
poration of the label by immunoprecipitation and phosphorimage anal-
ysis. The results showed that the biosynthesis rate of N1/−- was not
reduced compared to the wt-CFTR (Fig. S2A and S2B).
The turn-over of stably expressed complex-glycosylated N1/−-CFTR
was assessed by pulse-chase labeling in BHK-21 cells. The t1⁄2 of N1/−
was reduced ~8-fold (t1⁄2 ~2 h), compared with wt-CFTR (t1⁄2 ~16 h),
as shown in Fig. 5A and 5B. The accelerated turn-over of the complex-
glycosylated N1/−-CFTR provides therefore a plausible explanation for
the reduction of its steady state level.
Based on recent reports showing that membrane protein can be de-
graded from the plasma membrane [8,36,37], we hypothesized that de-
letion HI-NBD2 might interfere with the CFTR recycling and lead to
premature endolysosomal proteolysis. To test this hypothesis, thetime (h)
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the presence of cycloheximide (CHX) and in the absence or presence of
lysosomal protease inhibitor NH4Cl. The degradation rate was unaltered
upon exposing the cells to NH4Cl agent that inhibits endolysosomal pro-
teolysis by dissipating the acidic luminal pH (Fig. 5C and D).
However, as previously reported for C-terminal truncated CFTR [22]
and rescued (r)-F508del-CFTR [8], the inhibition of 26S proteasome ac-
tivity slowed down the disappearance of N1/−-CFTR (Fig. 5C). The disap-
pearance of the complex-glycosylated was inhibited ~2-fold by
lactacystin. While the peptide aldehyde, MG132, exerted a less pro-
nounced effect (Fig. 5C and D).
3.6. The biochemical structure of N1/−-CFTR is preserved
Our results provide the ﬁrst direct evidence that the biochemical
half-life of the complex-glycosylated N1/−-CFTR is ~8-fold shorter
than its wt counterpart at 37 °C, suggesting however that structural dif-
ferences may persist between the N1/−- and wt-CFTR at the plasma
membrane. To compare the conformational stability of the complex-
glycosylatedwt- andN1/−-CFTR, in vivo thermostability, in situ protease
susceptibility and thermoaggregation assays were performed.
The temperature dependence of the turnover of the complex-
glycosylated wt and N1/−-CFTR was compared by metabolic pulse-
chase studies (Fig. 6A and B). A minor difference was observed in the
turnover of the complex-glycosylated N1/−-CFTR at 40 °C (t1/2 ~2.5 h)
compared to 37 °C (t1/2 ~3 h) (Fig. 6C and D). Also, the turnover of the
wt-CFTR was also marginally affected at 40 °C (t1/2 ~17.5 h vs. ~18 h
at 37 °C), and was slow down at 26 °C (Fig. 6A and B). The simplestinterpretation of these data is that N1/−construct, like wt-CFTR, has a
compact tertiary structure that is resistant to the unfolding processes.
This ensures the stability of both proteins at elevated temperatures,
leading to their resistance to thermodenaturation and proteolysis.
The limited proteolytic digestion in conjunction with immunoblot-
ting was used to probe the conformation of the cytosolic domains of
CFTR protein. This method has been used to show the presence of
conformational difference between the wt, the F508del-CFTR and
the C-terminal truncated CFTR [22,30]. Intact microsomes prepared
from BHK cells were enriched in the complex-glycosylated wt or
N1/−-CFTR, and subjected to limited proteolysis in the presence of an in-
creasing concentration of trypsin. Immunoblot analysis of the proteolyt-
ic fragments with the L12B4 anti-CFTR Ab recognizing the NBD1
demonstrated a similar proteolytic digestion pattern between wt- and
N1/−-CFTR. Increased protease sensitivity of the core-glycosylated
F508del-CFTR compared to wt- and N1/−-CFTR was reproducibly
observed (Fig. 7A). The resistance of NBD1 domain to enzymatic
digestion, even after HI-NBD2 deletion, suggests that this region did
not affect the global HI-NBD1 folding nor CFTR conformation. Additional
thermoaggregation assays support this idea.
SDS-solubilized cell lysates, obtained from BHK cells expressing
N1/−- or wt-CFTR, were heat-denatured at temperatures ranging from
37 °C to 100 °C. Insoluble aggregates were eliminated by centrifugation
and monomeric CFTR remaining in the supernatant was quantiﬁed by
immunoblotting. The thermostability of solubilized CFTRwas character-
ized by measuring the aggregation temperature (Ta), at which 50% of
monomeric CFTR are converted into SDS-resistant aggregates (Fig. 7B).
The Ta of core-glycosylated F508del-CFTR was ~16 °C and ~12 °C
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counterparts, respectively (Fig. S3A). Similar results were observed
with all the other CFTR constructs (Fig. S4B and S4C). Finally, and most
importantly, no signiﬁcant difference between the thermoaggregation
tendency of N1/−- and wt-CFTR was detected when heat-denaturation
was performed in LSB supplemented with 8 M urea (Fig. 7B and S3D);
suggesting that urea denaturation of residual structural elements,urea -
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Fig. 7. In situ protease susceptibility and thermoaggregation of wt, F508del (dF) and N1/−-
was performed at the indicated concentrations of trypsin for 15 min at 4 °C. Samples were
N1/−-CFTR-expressing cells were solubilized in 2× Laemmli sample buffer (LSB), and sample
and CFTR remaining in the supernatant were visualized as indicated in Fig. 7A. Where indicateprevailing in SDSmicelles, abolishes the differences in the thermostabil-
ity of CFTR variants.
3.7. Deletion of HI-NBD2 region perturbs the quaternary structure of CFTR
The rapid degradation of mature N1/−-CFTR despite the lack of ap-
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d, heat denaturation was performed in 2× LSB supplemented with 8 M urea.
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had reported that CFTR exists as monomers, dimers, and/or multimers
in mammalian cells [38–44]. To date, no biochemical consequences of
the dimerization processes on CFTR behavior have been reported and
no role was allocated to any of the CFTR region for this process.
Hence, we assessed the quaternary structure of N1/−- and wt-CFTR
stably expressed in BHK cells using three experimental approaches.
The non-dissociative gel electrophoresis method [PFO-PAGE], which al-
lows the study of the quaternary structure of cytosolic and membrane
proteins [45], the photoactivatable amino acid cross-linking, a direct
way to identify dimerization in its cellular environment [27], and the
proximity ligation assay (PLA) for in situ visualization and quantiﬁca-
tion of membrane protein dimerization in intact cells [46].
First, analysis of BHK membranes expressing N1/−-, F508del-, and
wt-CFTR by PFO-PAGE revealed both a major and a minor bands
(Fig. 8A). The major band migrated as a ~170 kDa, consistent with
the molecular mass reported for the complex glycosylated form of
wt-CFTR, and as a ~140 kDa protein, corresponding to the complex
and to the core-glycosylated forms of N1/−- and F508del-CFTR protein,
respectively (Fig. 8A, PFO).
As previously reported [45], the minor band migrated as a larger
protein (~440 kDa), possibly a CFTR-containing dimer (Fig. 8A, PFO).
This band was not detected for F508del- and N1/−-CFTR, suggesting
that the immature and themature forms of F508del- and N1/−-CFTR, re-
spectively, are not competent for the dimerization. Moreover, theC
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of L-photo-leucine and L-photo-methionine (pLM) and then irradiated with UV (+) or not (−
munoblot using anti-HA or anti-EEA1 (early endosome antigen 1) mAbs. Cross-link indicates
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assay (PLA) of BHK cells co-transiently transfectedwith epitope-tagged CFTR constructs. BHK Ce
orMyc epitopes were subjected to PLA as described inmaterial andmethods. PLA signal (red) c
PLA signal was performed on ~50 transfected cells per condition in three independent experimhigher molecular weight observed on the PFO-Gel is unlikely to corre-
spond to aggregate CFTR induced by the PFO-detergent, since the
CFTR complex could be dissociated by treatment of PFO solubilized
membranes with SDS (Fig. 8A, SDS).
To conﬁrm the PFO-PAGE results, we investigated in intact living
cells the quaternary structure of CFTR proteins using the photo-cross-
linking via photoactivatable amino acids (methionine and leucine).
These amino acids were used in mammalian cells to efﬁciently cross-
linked transmembrane proteins after photoactivation [27]. BHK cells,
stably expressing wt, N1/−, and F508del-CFTR, were incubated with
photo-methionine and photo-leucine and UV irradiated to stimulate
the formation of covalent CFTR dimers (Fig. 8B). In the absence of
photo-amino acids, no cross-linkingwas detected (Fig. 8B, left). In sam-
ples irradiated in the presence of photo-amino acids (Fig. 8B, right), we
observed that only wt-CFTR showed a weak amount of a cross-linked
dimers, supporting a role of HI-NBD2 in CFTR dimerization. Cross-
linking with the photo-amino acids was not limited to transfected pro-
teins. The endogenous protein EEA1 (early endosome antigen 1) was
also cross-linked [Fig. 8B].
Finally, we used the proximity ligation assay (PLA) to visualize and
quantiﬁed the dimerization signal in intact cells. In our approach, two
different CFTRmonomers (wt, N1/−, or F508del-) tagged at the carboxy
terminus with either the HA or Myc epitope, were co-expressed in BHK
and COS-7 cell lines. CFTR-HA and CFTR-Myc proteins were detected
using rabbit anti-HA and mouse anti-Myc primary antibodies. TheD
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). Cross-linked products formed after UV irradiation were detected by SDS-PAGE and im-
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rabbit IgG as described in methods section. In transiently transfected
COS-7 cells, our results showed an increase in PLA signal for wt-CFTR
compared to N1/−-, or F508del-CFTR protein (Fig. 8C). The ﬂuorescently
labeled bundle represents the formation of one molecular interaction
that corresponds to CFTR dimer formation in individual cells.
For quantiﬁcation, only CFTR expression-positive cells detected co-
stained with FITC-conjugated anti-CFTR antibody were analyzed by
Blobﬁnder 3.1 software (Uppsala University). From analyzing 50
transfected cells per experiment, a 6 fold increase in PLA signal/cell
was detected in wt-CFTR compared to N1/−-, or F508del-CFTR
(Fig. 8D). The cells transfected with empty plasmid were used as a neg-
ative control for the PLA assay.
4. Discussion
ATP-driven tight dimerization of CFTR's cytoplasmic NBDs is link to
opening of the ion channel in the transmembrane domains [47]. This es-
tablishes a conserved coupling mechanism, whereby signals from the
NBDs are transmitted to the intracellular loops (ICLs) of TMDs to
cause substrate transport [48]. Such rearrangements, initiated by NBD
dimerization, might also affect the CFTR folding, trafﬁcking and mem-
brane stability.
We investigated the role of the putative heterodimeric interface (HI)
of NBD1 andNBD2 inwt andmutant CFTR (F508del) using the powerful
SOE by PCR technique. The mean advantage of this method is that the
splice site is not dependent on the pre-existing restriction enzyme rec-
ognition site and does not involve the inclusion or alteration of any
amino acid [23].
The conserved NBDs form a sandwich around two ATPs, with each
site for ATP binding and hydrolysis requiring both domains [11]. Based
on the deﬁnition of an ABC NBD [1], HI-NBD1 and HI-NBD2 boundaries
were deﬁned from amino acids 433 to 586 and 1220 to 1386, respec-
tively. Two subdomains characterize eachNBD. The catalytic subdomain
contains the conserved Walker A and B motifs, and Q — but not the
H-loop, and the alpha-helical subdomain contains the ABC signature
motif, LSGGQ (Fig. 1B) [15]. The importance of the H-loop for the ABC
member's activities was reported solely by Campbell et al. [49] and
the conserved histidine (His) residue is missing from the mouse and
the human CFTR NBD1 sequence [1]. However, based on the analogy
with NBDs of other ABC transporters, it has been predicted that the
H-loop of NBD2participates in hydrolysis of ATP bound at this particular
site [21,34,50], thereby contributing to channel closing, but not affecting
the CFTR trafﬁcking [51]. Nevertheless, the capacity of binding ATP for
our constructs, was preserved (Fig. 3D), suggesting that this process
was not altered by the deletion of HI-NBD1 or HI-NBD2.
Deletion of HI-NBD1 or HI-NBD2 did not affect the biogenesis, the
membrane insertion, and orientation as was conﬁrmed by pulse-chase
experiments and trypsin digestion [Figs. 2, 4D and 7A]. In the absence
of HI-NBD2, CFTR was normally addressed to the plasma membrane,
and deletion of F508 in HI-NBD1 region mimics the effect of delF508
mutation, conﬁrming that both regions are neither functionally nor bio-
chemically equivalent.
Glycosidase, immunoﬂuorescence, and cell surface biotinylation as-
says conﬁrmed the presence of N1/−-CFTR at the plasma membrane
[Figs. 2 and 3]. The maturation efﬁciency of N1/−-CFTR conﬁrms that
HI-NBD2 region is not a key element in ER quality control of CFTR pro-
tein. Similar results have been reported for C-terminal truncated CFTR
[52,53], suggesting that up to MSD2 boundary CFTR is under ER quality
control machinery. Excepting the maturation process, the other features
of the CFTR construct that was lacking the last 233 residues (1248X)
including the HI-NBD2 region [53], such as function and membrane sta-
bility, were altered in N1/−-CFTR construct. Indeed, despite the matura-
tion, glycosylation, and plasma membrane expression, no chloride
channel activity was observed even if the ATP binding capacity was pre-
served among all our constructs [Fig. 3D]. This is in agreement withpreviously published data on the role of HI-NBD2 region in CFTR Cl−
channel activity [47], and the known function of this region as a second
site for ATP hydrolysis, which drives channel gating by tight dimerization
of NBD1 andNBD2 domains [54].We observed that the residence time of
the complex-glycosylated N1/−-CFTR was dramatically decreased
(Fig. 5). Our results cannot be attributed to a miss-sorting from trans-
Golgi or endosomal compartment since N1/−-CFTR is targeted to the
plasma membrane with comparable efﬁciency to its wt counterpart
(Fig. 4B). The degradation rates of the complex-glycosylated N1/−-CFTR
were delayed in the presence of lactacystin, the most speciﬁc inhibitor
of proteasome [55]. Therefore, HI-NBD2 region might confer stability to
the mature CFTR by several mechanisms or a combination thereof.
Deletion of the HI-NBD2 that binds HI-NBD1 sequence through
Phe508-containing surfacepatchmay facilitate proteasomal degradation
by compromising endosomal sorting for recycling [56–58]. Such amech-
anism has been proposed for rescued (r)-F508del- and for the truncated
C-terminal Δ70-CFTR [8,22]. Both molecules have been shown to be un-
able to reach a correct foldable state necessary to escape the plasma
membrane quality control (PMQC) process that has been well docu-
mented. However, compared to r-F508del- andΔ70-CFTR this possibility
appears to be unlikely, since neither enhanced protease susceptibility
nor decreased in vivo thermostability and thermoaggregation tendency
were observed for N1/−-CFTR protein (Figs. 6 and 7). Finally, the absence
of the HI-NBD2 region may destabilize the quaternary structure of CFTR,
increasing the portion of monomer molecules that are susceptible to
proteolysis.
Three complementary approaches were used to investigate the qua-
ternary structure proﬁle of the wt-, F508del- and N1/−-CFTR. Combining
in situ Proximity Ligation Assay (PLA), UV-cross-linking using photo-
activated amino acids, and PFO assays, we showed thatHI-NBD2 deletion
inhibited the formation of a CFTRdimer structure compared towt [Fig. 8].
Interestingly, deletion of F508 has a similar effect reinforcing the role of
F508 in the CFTR quaternary structure, since r-delF508-CFTR is rapidly
degraded from the plasma membrane [59]. In the ABC superfamily,
multidrug-resistant P-glycoprotein (MDR) was also shown to exist as a
dimer or higher ordered oligomeric species in the plasma membrane
[60]. Such complex was believed to be stabilized by domain–domain in-
teraction particularly for the NBD1 domain. For the 3-hydroxy-3-
methylglutaryl-CoA reductase (HMGR) protein, interaction through the
cytosolic domain was shown to be important for its membrane stability,
and the loss of such interaction causes its degradation [61].
The hypothesis that CFTR may exist in a dimeric structure is not
novel. Compared to prokaryotic ABC proteins [62], CFTR is encoded by
a single gene that produces one functional polypeptide chain containing
the four characteristic ABC domains. Today, some structural data sug-
gest that CFTR may acquire, depending on the conditions, a quaternary
structure. Whereas the co-immunoprecipitation, biochemical and crys-
tallization results concluded that functional CFTR is predominantly in a
monomeric state [29,63–66], several studies have reported thepresence
of an oligomeric structure for CFTR. Freeze-fracture images [39], atomic
force microscopic [42], and functional evidence using patch-clamp ex-
periments [38] demonstrated that CFTR forms a dimer-like structure.
Tandem-linked heterodimers of wt- and a R-domain mutant CFTR
showed that two CFTR molecules interact to form a single ion con-
ductance pore via the cross-linking of the PDZ motif of the CFTR
C-terminal tails and the bivalent PDZ domains of sodium hydrogen ex-
change regulatory factor (NHERF) [40,41]. Biochemically, dimeric CFTR
was also reported to be the predominant form in the plasmamembrane
[43,44].
Besides being of fundamental importance for the CFTR channel ac-
tivity, our results showed that HI-NBD2 domain is also critical for
CFTR plasma membrane residency by stabilizing its quaternary struc-
ture.Moreover, our results point out the role of F508 in the dimerization
process. These ﬁndings further support our hypothesis that oligomeri-
zation of CFTRmolecules stabilizes the protein and that themonomeric
state results in a faster degradation.
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